Organon Plans Third Quarter 2024 Financial Result Announcement
Organon to Release Third Quarter 2024 Results
Organon (NYSE: OGN), a prominent global healthcare company dedicated to women's health, has announced the upcoming release of its third quarter 2024 financial results. The results are scheduled to be made public on October 31, 2024, just before a live webcast and conference call at 8:30 a.m. EDT, allowing stakeholders to gain valuable insights into the company's financial performance.
Understanding IPR&D and Financial Impact
For the third quarter of 2024, Organon anticipates a notable milestone expense of $51 million. This amount translates into an estimated impact of around $0.16 on both GAAP and non-GAAP earnings per share. Of this expenditure, it is expected that $50 million will be associated with a denosumab biosimilar candidate, under an ongoing license agreement with Shanghai Henlius Biotech, Inc.
Milestone Expectations
It's important to note that Organon has opted not to forecast IPR&D (in-process research and development) or related milestones, given the inherent uncertainties associated with predicting the timing of these developments. Consequently, the aforementioned milestones, along with any future IPR&D expenses, are not included in the financial guidance provided on August 6, 2024. As the quarter's financial results are still pending finalization, they remain subject to standard closing procedures. This introduces a degree of variability, making it necessary for stakeholders to consider that actual results may differ from the preliminary estimates.
Accessing the Webcast for Financial Results
Those interested in accessing the live call can do so via the Organon website, where the webcast will be available. A recording of the event will also be provided approximately two hours after the conclusion of the live discussion, ensuring that interested parties can catch up on the insights shared.
Registration for Participants
Institutional investors and analysts who wish to participate in this event need to register in advance. Upon registration, they will receive a confirmation email containing details for joining the conference call. This includes important information such as dial-in instructions, a unique passcode, and a registrant ID, allowing them to join the call directly without waiting for an operator.
About Organon and Its Mission
Organon is committed to enhancing women’s health by offering over 60 medicines and products that cater to various needs. The company’s expansive portfolio features biosimilars along with a broad range of established pharmaceuticals across diverse therapeutic areas. Focused on fostering growth in women’s health, Organon invests in innovative solutions and research while actively seeking collaborations with biopharmaceutical partners.
Global Reach and Workforce
With an extensive geographical footprint and impressive commercial capabilities, Organon employs approximately 10,000 people globally, operating with its headquarters in Jersey City, New Jersey. Its mission is central to its operations, striving to improve health outcomes for women throughout their lives.
Frequently Asked Questions
1. When will Organon announce its third quarter results?
Organon is set to announce its third quarter 2024 financial results on October 31, 2024.
2. What is the expected financial impact for the third quarter?
The company anticipates recognizing a milestone expense of $51 million, impacting earnings per share by approximately $0.16.
3. Will IPR&D expenses be included in the financial guidance?
No, IPR&D expenses and milestones are not included in the financial guidance due to uncertainty.
4. How can I access the webcast?
The live webcast of the conference call can be accessed on the Organon website.
5. What is Organon's primary mission?
Organon is focused on improving women's health through the provision of medicines and innovative solutions.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Unlocking Two Decades of Growth: The Journey of American Financial Group
- Raymond James Financial Boosts Revenue Growth with Investment Banking
- Apache Corporation's 2024 Tree Grant Program Supports Communities
- SpineGuard's Third Quarter Revenue Surges 20% Year-Over-Year
- Quarterly Tender Offer Announced by BNY Mellon Fund
- AccessHope Earns Recognition in 2024 Luminaries Awards
- Planisware Releases 2024 Half-Year Financial Insights
- Symbotic Inc. Faces Class Action Lawsuit Over Financial Disclosures
- Live Oak Bancshares to Unveil Q3 2024 Results Soon
- Empowering Women Veterans: PVA's 2024 Retreat Experience
Recent Articles
- Innovative Hydrogen Transportation Network Sets New Standards
- Surging Home Inventory Signals Potential Price Drops Ahead
- DocGo Strengthens Partnership with Bayhealth for Future Growth
- Revolutionizing Healthcare: WELL Health's AI Scribe Advancements
- GeoPark's Thriving Operations Fuel Strong Growth Prospects
- Boardwalktech Partners with Sophic for Market Growth Strategy
- Bowman Consulting Group Secures VDOT Engineering Services
- Americas Gold and Silver Executes Strategic Galena Consolidation
- Americas Gold and Silver Advances Galena Acquisition Efforts
- Tesla's Impressive Growth in EV Sales in China Market
- Market Trends and Predictions for the Tech Sector Ahead
- Tesla's Growth in China: Rising Sales and Future Plans
- Innovative Ideas at the TCI Network Conference in Mexico
- Join Sobi's Insightful Q3 2024 Conference Call on Earnings
- Snap-On's Financial Landscape: Insights and Future Growth Prospects
- Heliospectra Appoints Piet Hein van Baar as New Plant Specialist
- Nisun International Projects Impressive $192.5 Million Earnings
- Americas Gold and Silver's Strategic Move in Galena Complex Acquisition
- Arsenal Capital Partners Launches Innovative Digital Advisory Board
- Entrada Therapeutics Takes Bold Steps in Duchenne Research
- Equifax Partners with Google Cloud to Enhance Data Analytics
- Major Contract Win for SemiCab with $10 Billion CPG Leader
- Can-Fite's Namodenoson Advances with FDA's Orphan Drug Status
- Canopy Growth Completes Strategically Important Wana Acquisition
- Viatris Shares Promising Phase 3 Results for EFFEXOR in Japan
- Zimmer Biomet to Host Third Quarter Earnings Conference Call
- Purespring Therapeutics Secures Major Funding to Combat Kidney Diseases
- Marex Group Expands FX Offerings with Hamilton Court Acquisition
- Panavance Therapeutics Unveils Encouraging Trial Results
- Circumference Group Strengthens Portfolio with VIP Acquisition
- Novavax's Latest COVID-19 Vaccine Gains EU Approval
- Exploring the Growth of the Food Stabilizers Market
- Exploring Vagus Nerve Stimulation for Enhanced Sound Perception
- LifeMD's Growing Market Presence and Strong Earnings Report
- Huckleberry Market to Surpass $1.88 Billion by the Next Decade
- Understanding the Risks of GenAI Attacks on Data Security
- Maison Solutions Achieves Compliance with Nasdaq Standards
- Baird Reaffirms Optimistic Outlook for WNS Limited Shares
- Growth Trajectory of the Heavy Duty Truck Market Through 2034
- Market Moves: Arcadium Lithium Surges while Tech Giants Slide
- Future of At-home Testing Kits: A Market on the Rise
- New Coverage Insights on Hewlett Packard Enterprise by Deutsche Bank
- Exploring the Thriving Coffee Substitute Market Growth Trends
- Abercrombie & Fitch: A Growth Stock With Bright Prospects
- Growing Demand for Peripheral Nerve Stimulators in Health
- RPM International Thrives in New Construction Boom Driven by Rate Cuts
- Ciena: Embracing Growth Amid the AI Network Transformation
- Discovering Net3.org's Revolutionary Beacon Network Initiative
- Boosty Labs Marks 7 Years of Excellence in Technology Solutions
- Ocular Therapeutix Set to Shine at October Ophthalmology Events